| |
::
Abstracts: April 2004 :: |
|
|
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
 |
Extracapsular
cataract surgery compared with manual small incision
cataract surgery in community eye care setting in western
India: a randomized controlled trail |
| |
Edited
by Dr. Tahir Mahmood |
Gogate PM, Deshpande M, Wormald RP, Deshpande
R, Kulkarni SR Br J Ophthalmol 2003; 87:667-72 |
| |
Cataract
is the chief cause of avoidable blindness in
India and throughout the world. There are an
estimated 9-12 million blind in India, half
of which can be attributed to cataract. It is
estimated that another three million develop
visually disabling cataracts each year. Cataract
extraction accounts for the majority of the
workload of ophthalmic units worldwide. Extracapsular
cataract extraction with posterior chamber intraocular
lens implantation (PCIOL) was the most frequent
surgical technique until the past decade.
The use of a smaller incision
with the advantages of faster rehabilitation,
less astigmatism and better postoperative vision
without spectacles led to phacoemulsification
becoming the preferred technique where resources
are available. However, cost, both in terms
of equipment and training has limited its use
in the developing world. Thus there is a dichotomy
with different standards of care between the
developed and the developing world. Manual small
incision surgery in which the nucleus is delivered
through a 6-6.5 mm scleral tunnel is claimed
to have similar advantages to phacoemul-sification.
High quality, high volume cataract surgery is
needed in community eye care centers to effectively
manage the large backlog of cataract blindness;
but so far the effectiveness of manual small
incision surgery has not been formally compared
to the established extracapsular technique in
this setting.
The purpose of this study was to study "manual
small incision cataract surgery (MSICS)"
for the rehabilitation of cataract visually
impaired and blind patients in community based,
high volume, eye hospital setting and to compare
the safety and effectiveness of MSICS with conventional
extracapsular cataract surgery (ECCE).
In this single masked randomized controlled
clinical trial, 741 patients, aged 40-90 years,
with operable cataract were randomly assigned
to receive either MSICS of ECCE and operated
upon by one of eight participating surgeons.
Intraoperative and postoperative complications
were graded and scored according to the Oxford
Cataract Treatment and Evaluation Team recommendations.
The patients were followed up at 1 week, 6 weeks,
and 1 year after surgery and their visual acuity
recorded.
This paper reports outcomes at 1 and 6 weeks.
706 of the 74 (95.3%) patients completed the
6 week follow up. 135 of 362 (37.3%) of ECCE
group and 165 of 344 (47.9%) of MSICS group
had uncorrected visual acuity of 6/18 or better
after 6 weeks of follow up. 314 of 362 (86.7%)
of ECCE group and 309 of 344 (89.8%) of MSICS
group had corrected postoperative vision of
6/18 or better. Four of 362 (1.1%) of ECCE group
and six of 344 (1.7%) of MSICS group had corrected
postoperative visual acuity less than 6/60.
There were no significant differences between
the two groups for intraoperative and severe
postoperative complications.
MSCIS and ECCE are both safe and effective techniques
for treatment of cataract patients in community
eye care settings. MSICS needs similar equipment
to ECCE, but given better-uncorrected vision. |
| |
| |
| |
| A
clinical follow up of PRK and LASIK in eyes
with preoperative abnormal corneal topographies
Schor P, Beer SMC, da Silva O,
Takahashi R, Campos M
Br J Ophthalmol 2003; 87:682-5 |
| |
Refractive
surgery is an increasingly popular procedure
to decrease spectacle or contact lens dependency.
The risks of refractive surgery are low on an
individual basis, but the impact on the population
must be carefully evaluated by the medical community.
Photorefractive keratectomy (PRK) and laser
in situ keratomileusis (LASIK) are two refractive
procedures currently leading the field. The
number of LASIK procedures has increased and
far surpasses the number of PRK procedures owing
to faster visual recovery, less pain, and greater
ametropic range capability. The intraoperative
risks related to LASIK are intrinsically greater
than those related to PRK. Postoperative complications
related to PRK include haze and regression which
have become major limitations of the procedure.
Long term complications related to LASIK include
ectasia due to corneal weakening, which is not
fully understood or well controlled.
The prevention of complications is a major goal
in these elective procedures. Realistic patient
expectations, night vision disabilities, and
transient discomfort must be discussed with
all patients before surgery, and a comprehensive
ophthalmological examination should be performed.
Current technology allows us to diagnose a limited
range of corneal diseases; therefore the potential
visual results of the procedures in abnormal
eyes are not clear.
The purpose of this study was to assess the
safety and predictability of photorefractive
keratotomy (PRK) and laser in situ keratomileusis
(LASIK) based on preoperative corneal topography.
A non-randomised comparative study was carried
out on 84 eyes that presented with topographic
abnormalities before undergoing PRK (n-44) or
LASIK procedures were performed on 168 eyes
using the Summit apex plus excimer laser. Topographic
abnormalities, including apex displacement (AD),
increased asphericity (AS), meridional irregularity
(MI), increased inferior superior asymmetry
(IS), increased curvature (CU), and combined
features (CO), were assessed preoperatively
using the Eye Sys analysis system. Safety and
predictability of the two procedures were defined
as a postoperative visual acuity of 20/40 or
better and the loss of one or more lines of
spectacle corrected visual acuity (SCVA).
All patients were followed for 6 months. There
was a significant loss of best corrected visual
acuity in the PRK-AD (p<0.001), PRK-CO (p<0.05),
and LASIK-AS (p<0.001) patients. The number
of eyes within plus or minus 1.0D of the surgical
plan postoperatively was similar in all groups.
These data suggest that although predictability
was similar, PRK and LASIK performed in corneas
with topographic abnormalities might cause loss
of vision. |
| |
| |
| |
| Comparison
of localized nerve fibre layer defects in normal
tension glaucoma and primary open angle glaucoma
Woo SJ, Park KH, Kim DM
Br J Ophthalmol 2003;87:695-8 |
| |
Many
researchers have suggested a difference in pathogenesis
between normal tension glaucoma (NTG) and primary
open angle glaucoma (POAG). Among the evidence
supporting this theory were the different patterns
of visual field defect and optic nerve head
configuration. The frequent occurrence of optic
disc haemorrhage and the high incidence of systemic
diseases in patients with NTG also suggested
that a damaging mechanism other than high intraocular
pressure contributed to the glaucomatous damage.
Although retinal nerve fibre layer (RNFL) evaluation
has become important in detecting glaucomatous
nerve damage, quantitative comparison of RNFL
photographs between NTG and POAG has been rare.
The purpose of this study was to compare the
pattern of localized nerve fiber layer (NFL)
defects in normal tension glaucoma (NTG) and
primary open angle glaucoma (POAG).
50 NTG eyes and 36 POAG eyes, all with localized
NFL defects, were enrolled. On retinal NFL photography,
the proximity of the defect to the center of
the fovea (angle a) and the sum of the angular
width of the defects (angle ß) were determined.
Angle a was the angle made by a line from the
center of the fovea to the disc canter and a
line from the disc center to the disc margin,
where the nearest border of the defect met.
The patterns of localized NFL defects in NTG
and POAG were compared with angles a and ß
. Independent t test was used for statistical
analysis.
Angle a in NTG (35.1 (SD 20.0)o) was significant
smaller than that of POAG (45.9 (21.9)o) (p=0.02),
while angle ß in NTG (49.0 (31.9)o) was
significantly larger than that of POAG (33.1
(23.9)o) (p=0.01).
The authors concluded that the pattern of NFL
defects in NTG was different from that in POAG.
Localised NFL defects in NTG were closer to
the fovea and wider in width than those in POAG. |
| |
| |
| |
Features
of abnormal Choroidal circulation in central
serous chorioretinopathy
Kitaya
N, Nagaoka T, Hikichi T, Sugawara R, Fukui
K, Ishiko S, Yoshida A
Br J Ophthalmol 2003;87:709-12
|
Central
serous chrioretinopathy (CSC) is characterized
by a focal serous detachment of the neurosensory
retina. Fluorescein angiography shows dye leakage
from the retinal pigment epithelium (RPE) and
subretinal dye pooling. However, fluorescein
angiography has not been useful in determining
the pathogenesis of CSC because of limitations
in imaging the choroidal vessels. Thus, while
the clinical features of CSC have been described,
its pathogenesis is controversial.
Numerous recent reports have described abnormalities
of the choroidal circulation using indocyanine
green (ICG) angiography. ICG is a dye that has
several advantages over sodium fluorescein for
choroidal angiography, in that it binds tightly
to plasma proteins and thus prevents marked
leakage from fenestrated vessels such as the
choriocapillaris. The dye also absorbs and fluoresces
in the near infrared range, which enhances visualization
of the fluorescence through hemoglobin, RPE,
or xantophyll. Using ICG angiography, choroidal
vascular abnormalities, such as filling delays
of the choroidal arteries and choriocapillaris,
venous dilation, and focal hyperfluorescence
of the choroids, which indicate hyperpermeability
of choroidal vessels, have been reported.
The purpose of this study was to evaluate abnormalities
in the choroidal circulation in cases of central
serous chorioretinopathy (CSC).
A complete clinical ophthalmological examination
was performed using simultaneous fluorescein
and indocyanine green (ICG angiography with
a confocal scanning laser ophthalmoscopy and
the digital images analysed in 36 consecutive
patients with acute CSC. To quantify the choroidal
circulation, the foveal choroidal blood flow
was measured in 11 patients using laser Doppler
flowmetry.
Fluorescein angiography showed focal leakage
from the retinal pigment epithelium in all patients.
ICG angiography revealed delays in arterial
filling in 27 eyes (75%). Abnormal choroidal
hyperfluorescence was observed in 30 eyes (83%).
The choroidal blood flow in eyes with CSC was
45% lower than in fellow eyes (p<0.01).
The author concluded with remarks that decreased
choroidal blood flow in CSC was demonstrated
for the first time. The decreased choroidal
blood flow might be correlated with the small,
localized hypofluorescent areas, which may indicate
non-perfused areas of the choriocapillaris that
are frequently seen during ICG angiography. |
| |
| |
| |
| Intraocular
pressure and visual field loss in primary angle
closure and primary open angle glaucomas
Gazzard G, Foster PJ, Devereux
JG, Oen F, Chew P, Khaw PT, Seah S
Br J Ophthalmol 2003; 87:720-5 |
| |
The
aetiology of glaucomatous optic neuropathy (GON)
is not fully understood. There are many implicated
risk factors, the two most consistent of which
appear to be intraocular pressure (IOP) and
age. However, direct correlations between the
extent of visual field loss (VFL) and the level
of pretreatment IOP at presentation have been
found to be weak for POAG. This probably reflects
the multiple interacting risk factors for damage
that modify the response of a particular nerve
to a given IOP. The probability of developing
glaucoma at a certain IOP may be different for
different types of glaucoma. Stronger correlations
between VFL and IOP have been seen in pseudoexfoliative
glaucoma, which has been thought to be a more
pressure dependent disease, than in POAG. Primary
angle closure glaucoma (PACG) may also be considered
to be a more purely pressure dependent disease
than POAG.
A strong correlation between pretreatment IOP
and the amount of visual field damage present
may be an indicator of the extent to which a
disease can be considered pressure dependent.
Such an association may support the belief that
the pathogenetic mechanisms involved in PACG
are more pressure dependent. This in turn might
have implications for prognosis and the need
for clinical trials to explore the extent to
which pressure lowering along may be successful
in halting the progression of optic nerve damage
and consequent VFL.
The purpose of this study was to compare the
correlation between visual field loss and the
pretreatment intraocular pressure (IOP) in primary
angle closure glaucoma (PACG) and primary open
angle glaucoma (POAG).
In a cross sectional observational study of
74 patients (43 PACG, 31 POAG), pretreatment
IOP was measured at presentation, before treatment
was initiated. The severity of visual field
loss was assessed by AGIS score, mean deviation
(MD), pattern standard deviation (PSD), and
corrected pattern standard deviation (CPSD).
Glaucomatous optic neuropathy was assessed from
simultaneous stereo disc photographs.
There was a stronger correlation between pretreatment
IOP and the extent of visual field loss in PACG
subjects than in those with POAG for both MD
(PACG: Pearson correlation coefficient (r) =0.43,
p=0.002; r2=0.19), (POAG: r =0.21, p = 0.13;
r2 = 0.04) and AGIS score (PACG: r = 0.41, p
= 0.003; r2 = 0.17), (POAG: r = 0.23, p = 0.19;
r2 = 0.05 respectively). No such associations
were seen for pattern standard deviation (PSD)
or corrected pattern standard deviation (CPSD)
in either group (p> 0.29). Both horizontal
and vertical cup-disc ratio were well correlated
with severity of field loss but not with presenting
IOP for either diagnosis.
The authors concluded with remarks that the
results of the study are consistent with the
hypothesis of a greater IOP dependence for optic
nerve damage in PACG than POAG and, conversely,
a greater importance of other, less pressure
dependent mechanisms in POAG compared to PACG. |
| |
| |
| |
| Interobserver
agreement on visual field progression in glaucoma:
a comparison of methods
Viswanathan AC, Crabb DP, McNaught
AI, Westcott MC, Kamal D, Garway-Heath DF, Fitzke
FW, Hitchings RA
Br J Ophthalmol 2003;87:726-30 |
| |
Several
scoring systems have been devised in order to
identify visual field progression for the purposes
of research but none has found widespread acceptance
in general clinical practice. However, unaided
clinical judgment is inconsistent: even expert
observers show considerable disagreement about
whether a given visual field series signifies
progression or stability. One possible reason
for this is that the standard output of most
automated perimeters provides inadequate information
relating to progression or stability. Thus,
when the clinician is attempting to decide whether
or not a given series of outputs constitutes
progressive disease; the task involves manually
comparing the decibel sensitivity values (or
processed versions thereof) of graphical plots
for all fields in the series. This task is further
complicated by the contributions of "within
test" variability (short term fluctuation)
and "between test" variability (long
term fluctuation), both of which are known to
be increased above normal in glaucoma. For these
reasons, and because the grids of numbers produced
by automated perimeters are easily amenable
to numerical analysis, a great variety of software
and statistical approaches have been taken to
aid in the determination of visual field progression
in glaucoma. One set of methods rely on estimates
of change in summary measures of the field such
as regression analysis of the mean defect value,
mean deviation, other global measures, measurement
of whole field and quadratic sensitivity losses,
and regression analysis of various estimates
of the sensitivity of the whole field or parts
of it. However, the analysis of summary measures,
whether based on the whole field or on clusters
of points within it, has been found to be "remarkably
poor" and of little value" in detecting
glaucomatous change. Summary measures largely
or completely ignore the detailed spatial information
contained within computerized field tests and
are insensitive to early localized change. Furthermore,
different regions of the visual field may deteriorate
at different rates.
The purpose of this study was to examine the
level of agreement between clinicians in assessing
progressive deterioration in visual field series
using two different methods of analysis.
Each visual field series satisfied the following
criteria: more than 19 reliable fields, patient
age over 40 years, macular threshold at least
30 db. The first three fields in each series
were excluded to minimize learning effects:
the following 16 were studied. Five expert clinicians
assessed the progression status of each series
using both standard Humphrey printouts and point
wise linear regression (PRO-GRESSOR). The level
of agreement between the clinicals was evaluated
using a weighted kappa statistic.
A total of 432 tests comprising 27 visual field
series of 16 tests each were assessed by the
clinicians. The level of agreement between the
clinicians was always higher when they used
PROGRESSOR (median kappa = 0.59) than when they
used Humphrey printouts (median kappa = 0.32).
This was statistically significant (p = 0.006,
Wilcoxon matched pairs signed rank sum test).
The authors concluded that the agreement between
expert clinicians about visual field progression
status is poor when standard Humphrey printouts
are used even when the field series studied
are long and consist solely of reliable fields.
Under these ideal conditions, clinicians agree
more closely about patients visual field progression
status when using PROGRESSOR than when inspecting
series of Humphrey printouts. |
| |
| |
| |
| Extent
of foveal tritanopia in diabetes mellitus
Davies N, Morland A
Br J Ophthalmol 2003;87:742-6. |
| |
Short
wavelength sensitive (S) cones are fewer in
number than medium wavelength (M) and long wavelength
sensitive (L) cones, representing approximately
10% of the total cone population. An early study
showed that the fovea was relatively insensitive
to short wavelength light and that colour vision
was impaired, colour matching being possible
with two primaries instead of the usual three.
It was thought initially that an absence of
rods was responsible for the changes seen in
visual function. Willmer and Wright1, however,
demonstrated the tritanopic nature of the colour
vision defect. They showed that dichromatic
colour matches consistent with congenital tritanopia
could be made for a 20 bipartite field. A similar
tritanopic colour vision deficit was reported
for small fields generally, suggesting that
the fovea may not be unique in this respect.
Other theories suggested that the apparent tritanopic
deficit in the fovea might be due to Troxler
fading or to preretinal screening of short wavelength
light by the increasing density of the macular
pigment. Anatomical study has also demonstrated
that the center of the fovea appears to be devoid
of S-cones in primates. The extent of the foveal
tritanopic region is around 20-25 minutes of
arc.
Studies of the Farnsworth Munsell 100 Hue test
in diabetics have shown an increased error score.
Some studies have shown generalized loss of
hue discrimination with no specific axis, while
others have demonstrated a red-green axis loss.
However, three studies have shown a loss of
colour discrimination on a tritanopic axis in
patients with diabetes.
The purpose of this study was to use a colour
matching technique to test the hypothesis that
the foveal tritanopic zone is increased in size
in diabetes mellitus.
A Wright tristimulus colorimeter was adapted
for small field colour matching and colour matches
were performed on bipartite fields in the range
12'to 60' of arc. The reference stimulus was
490 nm desaturated with 650 nm and the matching
stimulus consisted of either two wavelengths
(530 nm and 650 nm) or three (460 nm, 530 nm,
and 650 nm). The size of the zone of foveal
tritanopia was measured using two alternative
forced choice presentations of dichromatic and
trichromatic matches made by the observer for
different field sizes. 21 diabetic and 12 controls
performed the experiment.
The results for the controls show a normal distribution,
with a median foveal tritanopic zone of 18'
of arc. The median for the diabetic patients
was also 18' of arc, but the distribution showed
a significant skew to the right. A non-parametric
test shows a significant difference in comparison
with the controls (p = 0.01), with several subjects
having extensive zones of foveal tritanopia,
reaching up to 1 degree.
The authors concluded that the majority of diabetic
subjects the extent of foveal tritanopia is
normal; however, there is good evidence that
in a small number of subjects the size of the
zone is significantly increased. This indicates
S-cone pathway damage that is sufficiently severe
to lead to dichromatic colour vision in the
fovea.
1. Willmer E, Wright W. Colour sensitivity of
the fovea centralis. Nature 1945; 156:119-21. |
| |
| Assessment
of colour vision as a screening test for sight
threatening diabetic retinopathy before loss
of vision
Ong GL, Ripeley LG, Newsom RSB,
Casswell AG
Br J Ophthalmol 2003;87:747-52 |
| |
Despite
effective treatments, diabetic retinopathy is
still the most common cause of blindness in
industrialized nations among the 20-60 years
old age group.
The detection of presymptomatic sight threatening
diabetic retinopathy (STDR) remains difficult.
Early treatment of proliferative diabetic retinopathy
and diabetic maculopathy improves visual outcome.
However, STDR should be detected before visual
damage has taken place as only a minority of
patients have improvement in vision following
laser treatment. With effective screening blind
registrations for patients under the age of
70 could be reduced by 10%. Screening is clinically
viable and cost effective and will be increasingly
important as the incidence of diabetes rises
over the next 10 years.
The purpose of this study was to assess the
effects of sight threatening diabetic retinopathy
(STDR) on colour vision and to evaluate automated
tritan contrast threshold (TCT) testing for
STDR screening before significant visual loss.
Patients were recruited from a hospital based
photographic screening clinic. All subjects
underwent best corrected Snellen visual acuity
(BCVA) and those with 20/30 vision or worse
were excluded. Automated TCT was performed with
a computer controlled, cathode ray tube based
technique. The system produced a series of sinusoidal,
standardized equiluminant chromatic gratings
along a tritan confusion axis. Grading of diabetic
retinopathy was made by one of the team of experienced
ophthalmic registrars (SpR) using slit lamp
biomicroscopy and a 78D lens; HbA1c and urine
albumin were also tested.
Patients with STDR had significantly worse TCT
despite normal BCVA (p<0.0001). TCT yielded
a sensitivity of 100% for detecting diabetic
maculopathy and 94% for STDR with a specificity
of 95%. Logistic regression analyses showed
that TCT (p<0.001) and HbA1c (p<0.05)
correlated significantly with he presence of
STDR but duration of diabetes, urine albumin
counts, and BCVA failed to show any significant
correlation. No associations between TCT and
duration of disease, TCT and HbA1c and TCT and
urine albumin counts were found.
The authors concluded that tritan colour vision
deficiency was observed in patients with STDR
despite their normal BCVA. These results indicate
that automated TCT assessment is an effective
and clinically viable technique for detecting
STDR, particularly diabetic maculopathy, before
visual loss. |
| |
| |
| Impact
of smoking on the response to treatment of thyroid
associated ophthalmopathy
Eckstein A, Quadbeck B, Mueller
G, Rettenmeier AW, Hoermann R, Mann K, Steuhl
P, Esser J
Br J Ophthalmol 2003;87:773-6 |
| |
Thyroid
associated ophthalmopathy (TAO) occurs more
frequently and tends to be more severe in smokers
than non-smokers. Current but not lifetime tobacco
use correlates with the severity of TAO. A prospective
study revealed that smoking increases the risk
of ophthalmopathy progression after radioiodine
therapy. A retrospective study showed that smoking
decreases the efficacy of orbital irradiation
and of glucocoriticoid therapy. According to
another retrospective investigation, however,
the final outcome does not seem to be influenced
by smoking habits.
In this prospective study, tobacco use was evaluated
by quantitative analysis of the haemoglobin
adduct N-2-hydroxyethylvaline (HEV). HEV is
formed from hydroxyethylating agents of cigarette
smoke and reflects the integrated "smoking
dose" over the lifetime of erythrocytes.
Although other sources of ethylene oxide (that
is, exhaust fumes, endogenous ethylene production")
influence the HEV concentration, a linear relation
between the number of cigarettes smoked per
day and the HEV levels has been observed (correlation
coefficient r = 0.54) indicating that HEV is
a suitable biomarker for active and passive
smoking.
In patients with Groves' disease, smoking considerably
increases the incidence and severity of thyroid
associated ophthalmopathy (TAO). The authors
sought to determine if smoking also influences
the course of TAO during treatment, and the
efficacy of therapy.
41 smokers and 19 non-smokers with moderate
untreated TAO were included in this prospective
study. All patients were treated with steroids
and, 6 weeks after the beginning of drug therapy,
with orbital irradiation. Follow up was performed
1.5,4.5, 7.5, and 12 months after beginning
of the study. Proptosis, clinical activity score
(CAS), and motility were evaluated. The extent
of smoking was derived from the concentration
of the haemoglobin adduct N-2-hydroxyethylvaline
(HEV), a parameter of long term smoking.
There was no difference in the clinical manifestations
of TAO between smokers and non-smokers at the
beginning of treatment. However, CAS decreased
(p<0.05) and motility improved (p<0.02)
significantly faster and to a greater extent
in non-smokers than smokers. Inverse correlations
between the CAS decrease and the HEV levels
observed 4.5 and 7.5 months after the beginning
of treatment and between the improvement of
motility and the HEV levels after 1.5, 4.5,
and 7.5 months indicated a dose dependence.
Mean HEV levels did not vary much during the
follow up period and were significantly different
in smokers (mean 5.4 (SD 2.7) ug/l) and non-smokers
(mean 1.8 (1.3) ug/l; p<0.01).
The authors concluded that smoking influences
the course of TAO during treatment in a dose
dependent manner. The response to treatment
is delayed and considerably poorer in smokers. |
|
| |
|
|